Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Fujirebiofujirebio.com · Low evidenceFujirebio is a global diagnostics company that develops and manufactures next-generation diagnostic content, including ultra-sensitive detection technologies and biomarkers for conditions like Alzheimer's disease, multiple sclerosis, and Parkinson's disease. The company offers its innovations through open partnerships, providing raw materials, reagents, and complete development and regulatory services to other technology providers.
Parse Score